clinical decision support
Anna Dover, director of product management at FDB, formerly First Data Bank, says drug-related clinical decision support alerts pose challenges for prescribers and pharmacists, but technology can optimize the process through refinement.
It uses a competitive learning approach against unlabelled data.
HIMSS23
Stacey Caywood, CEO of Wolters Kluwer Health, discusses how Wolters Kluwer solutions incorporate diversity and inclusivity into the text, images and clinical support sources they provide to help clinicians meet patients’ care needs.
HIMSS23
Digital therapeutics improve access to care, but face reimbursement challenges. Jessica Hauflaire, COO of the Digital Therapeutics Alliance, describes the DTA's work with CMS and policymakers to gain support for this new care model.
HIMSS23
Dr. John Showalter, CPO at Linus Health, describes drug therapy advances for Alzheimer's and how technology can help screen and identify at-risk patients sooner to optimize outcomes and quality of life.
HIMSS23
Anna Dover, director of product management at First Databank, discusses First Databank's medication decision support technology, which helps keep clinicians informed about prescription drug information without overwhelming them.
HIMSS23
Josh Rubel, MDClone's chief commercial officer, talks about the need for healthcare organizations to manage and protect large volumes of patient data and use it for clinical decision support while respecting security regulations.
HIMSS23
In this highlight of his HIMSS23 presentation about health IT's ability to battle sepsis, Christopher Girardo, fellow, clinical informatics/PRN staff, pathology, at LSU Health Shreveport and Ochsner Health, explains certain points.
HIMSS22
Speaking with companies who showcase their latest transformative products in the healthcare industry.
The company is also close to getting its patent for the Us2.v1 software recognised in the US.